- Home
- RVT vs OLMA Comparison
RVT vs OLMA Comparison
Compare RVT & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVT | OLMA |
|---|---|---|
| Founded | 1986 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | RVT | OLMA |
|---|---|---|
| Price | $16.41 | $14.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $44.89 |
| AVG Volume (30 Days) | 224.3K | ★ 1.6M |
| Earning Date | 01-01-0001 | 03-16-2026 |
| Dividend Yield | ★ 7.32% | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ 2.95 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $347.47 |
| P/E Ratio | $5.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.12 | $2.86 |
| 52 Week High | $18.73 | $36.26 |
Technical Indicators
Market Signals| Indicator | RVT | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 39.18 | 28.57 |
| Support Level | $15.77 | $4.35 |
| Resistance Level | $16.50 | $27.38 |
| Average True Range (ATR) | 0.45 | 1.20 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 25.00 | 19.24 |
Price Performance
Historical ComparisonAbout RVT Royce Value Trust Inc.
Royce Value Trust Inc is a diversified closed-end investment company. It invests in diversified sectors including consumer discretionary, consumer staples, healthcare, financial, IT, telecommunications, and materials. The company's portfolio includes common stocks, preferred stocks, corporate bonds, and repurchase agreements. The company invests in Industrials, Financials, Information Technology, Materials, Health Care, Communication Services, Real Estate and others.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.